Clinical Trial Update: Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether the SLC30A8 rs13266634 genetic variant alters the glycemic response to zinc supplementation in Egyptian patients with Type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: Cairo University | Conditions: Diabetes Mellitus, Type II | Phase 4 | Status: COMPLETED